CAVT® Computer Assisted Vacuum Thrombectomy platform by Penumbra® harnesses advanced computer technology designed to enable rapid restoration of blood flow in cases such as pulmonary embolism (PE), venous thromboembolism (VTE), and acute limb ischemia (ALI).
The platform utilizes the Penumbra ENGINE® Aspiration Source, which delivers nearly pure, continuous vacuum (-29 inHg or -98.2 kPa) to our catheters, engineered to enable thrombus removal in a wide range of vessel sizes.
Lightning Flash® Stands Alone
The Lightning Flash system by Penumbra is designed to enhance the safety, speed, and simplicity of PE treatment and VT removal. It is the only mechanical thrombectomy system with Level 1 Evidence compared to the standard of care.a
The Fastest Device for the Treatment of PE
Reported Device Times in Minutesb

a. As of September 2026.
b. The definition of device time varies between studies. See citations and corresponding publications for specific definitions.
c. STORM-PE demonstrated a median device time of 25 minutes utilizing Lightning Flash 1.0 and 2.0.
d. Safety and feasibility single-arm study (n=25).
1. Lookstein RA, Konstantinides SV, Weinberg I, et al. Randomized controlled trial of mechanical thrombectomy with anticoagulation versus anticoagulation alone for acute intermediate-high risk pulmonary embolism: primary outcomes from the STORM-PE trial. Circulation. 2026 Jan 6;153(1):21-34. doi:10.1161/CIRCULATIONAHA.125.077232. Median thrombectomy time 25 min.
2. Bangalore S, Tomalty RD, Kado H, et al. Prospective multicenter IDE study of the next-generation precision aspiration thrombectomy system for intermediate-risk pulmonary embolism: the SYMPHONY-PE trial. Circ Cardiovasc Interv. 2026 Nov;18(11):e015815. Median device use-time of 31 min.
3. Keeling WB, Ranade M. Evaluating the safety and efficacy of the AlphaVac F1885 system in acute intermediate risk PE patients: APEX-AV trial. J Soc Cardiovasc Angiogr Interv. 2024;3(5)(suppl):101876. [Abstract LB-7] doi:10.1016/j.jscai.2024.101876. Mean Procedural time (device time) 37.2 min.
4. Sabri S, Horr S, Stegman B, et al; on behalf of the AVENTUS Trial Investigators. Novel aspiration thrombectomy and blood reinfusion system for acute intermediate-risk pulmonary embolism: AVENTUS trial results. J Soc Cardiovasc Angiogr Interv. 2025 May 2;4(7):103661. doi:10.1016/j.jscai.2025.103661. Median catheter dwell time of 39.5 min.
5. Jaber WA, Gonsalves CF, Stortecky S, et al. Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: Primary results of the PEERLESS randomized controlled trial. Circulation. 2025 Feb 4;151(5):260-273. doi:10.1161CIRCULATIONAHA.124.072364. Treatment catheter dwell time 47.9 min. (Mean).
6. Kobayashi T, Secemsky EA, Klein AJ, et al. A safety and feasibility single-arm study of a novel catheter thrombectomy device for the treatment of pulmonary embolism (ENGULF). J Soc Cardiovasc Angiogr Interv. 2024 May 3;3(6):102049. doi:10.1016/j.jscai.2024.102049. Mean procedure time from device insertion to removal was 57.4 min.
7. Toma C. Impact of a blood return system on mechanical thrombectomy-associated blood loss and hemodynamic outcomes in a pulmonary embolism registry. European Heart Journal. 2022 Oct;43(Suppl 2):ehac544.1893. doi:10.1093/eurheartj/ehac544.1893.
Pulmonary Embolism Cases
Images used with permission and provided for illustrative purposes only. Procedural techniques and decisions based on physician’s medical judgment. Individual results may vary. Consents on file at Penumbra, Inc.
Join us for Continuing Medical Education Opportunities designed to train healthcare professionals on disease states, care pathways, treatment options, clinical treatment standards, outcomes, and CAVT applications.
Complete Arterial Platform
Advancing ALI Care
Lightning Bolt® technology by Penumbra is an advanced arterial thrombectomy system. Designed with intelligent, Modulated Aspiration, it can identify friction within the catheter and automatically adjust aspiration to help overcome resistance and designed to optimize clot removal.
Designed for rapid, efficient, thrombus extraction, Lightning Bolt technology supports an endovascular-first approach across a broad range of arterial cases, engineered to help physicians restore blood flow quickly and minimize the need for more invasive management options.
CAVT hardware as seen in Lightning Bolt
Arterial Cases
Images used with permission and provided for illustrative purposes only. Procedural techniques and decisions based on physician’s medical judgment. Individual results may vary. Consents on file at Penumbra, Inc.
The Complete CAVT Platform
-
Lightning
Flash 3.0

Lightning Flash 3.0 features next-gen CAVT software for the removal of VT and treatment of PE.
-
Select +
Catheter

Packaged with Lightning Flash 3.0, the Select +™ catheter is engineered for the pulmonary anatomy.
-
ELEMENT
Sheath

ELEMENT™ Vascular Access System is the first laser-cut hypotube sheath designed for venous thromboembolism (VTE).
-
Lightning
Bolt 12

Lightning Bolt 12 is designed to address VTE with Modulated Aspiration and is engineered for improved clot removal efficiency.
-
Lightning
Bolt 7
Lightning Bolt 7 uses Modulated Aspiration designed to rapidly remove large, fibrous blood clots in the arteries with minimal blood loss.
-
Lightning
Bolt 6X with TraX
Lightning Bolt 6X with TraX™ features advanced coil-winding designed for superior trackability and an enhanced hydrophilic coating designed for smoother navigation.
Want to Learn More?
Contact us to learn more about CAVT and schedule a demo